CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L603. A total of 24 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,666 | -39.8% | 4,697 | 0.0% | 0.00% | – |
| Q2 2023 | $2,767 | +3.2% | 4,697 | 0.0% | 0.00% | – |
| Q1 2023 | $2,680 | -14.4% | 4,697 | 0.0% | 0.00% | – |
| Q4 2022 | $3,132 | -55.3% | 4,697 | 0.0% | 0.00% | – |
| Q3 2022 | $7,000 | +40.0% | 4,697 | 0.0% | 0.00% | – |
| Q2 2022 | $5,000 | -93.6% | 4,697 | -81.7% | 0.00% | – |
| Q1 2022 | $78,000 | -25.7% | 25,666 | -4.6% | 0.00% | – |
| Q4 2021 | $105,000 | -22.8% | 26,899 | +4.2% | 0.00% | – |
| Q3 2021 | $136,000 | -12.8% | 25,825 | -2.1% | 0.00% | – |
| Q2 2021 | $156,000 | – | 26,373 | +67523.1% | 0.00% | – |
| Q1 2021 | $0 | – | 39 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 39 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 39 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 39 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 462,659 | $1,411,000 | 0.58% |
| Sio Capital Management, LLC | 422,598 | $1,289,000 | 0.43% |
| SPHERA FUNDS MANAGEMENT LTD. | 508,322 | $1,550,000 | 0.22% |
| Affinity Asset Advisors, LLC | 400,000 | $1,220,000 | 0.20% |
| Atom Investors LP | 31,385 | $96,000 | 0.04% |
| Ikarian Capital, LLC | 104,741 | $319,000 | 0.04% |
| Schonfeld Strategic Advisors LLC | 514,780 | $1,570,000 | 0.01% |
| PURA VIDA INVESTMENTS, LLC | 77,568 | $237,000 | 0.01% |
| Point72 Asset Management, L.P. | 230,000 | $702,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 58,934 | $179,000 | 0.00% |